GLycaemic Index Dietary Education for glucose abnormalities in cystic fibrosis (GLIDE) - a feasibility study

niversity of Bristol0 个研究点目标入组 24 人开始时间: 2018年7月25日最近更新: 2022年8月22日

适应症

试验速览

暂无简介。

•Current inclusion criteria as of 12/08/2022:
•1. Aged 11-35 years
•2. CF diagnosis based on either genotype and/or phenotypic presentation
•3. Established CFRD or at risk of developing CFRD as defined by:
•3.1. HbA1c = 6.5%
•3.2. Previously recorded abnormal oral glucose tolerance test (OGTT), defined as a 120-minute plasma venous sample =7.8mmol/l
•3.3. Previous abnormal continuous glucose monitoring (CGM) result, defined as CGM time above 7.8 mmol/l =4.5%
•Previous inclusion criteria:
•1. Aged 11-30 years
•2. CF diagnosis based on either genotype and/or phenotypic presentation
•3. Established CFRD or at risk of developing CFRD as defined by:
•3.1. HbA1c = 6.5%
•3.2. Previously recorded abnormal oral glucose tolerance test (OGTT), defined as a 120-minute plasma venous sample =7.8mmol/l
•3.3. Previous abnormal continuous glucose monitoring (CGM) result, defined as CGM time above 7.8 mmol/l =4.5%

•1. Pregnant/planning pregnancy
•2. Understanding/command of English not of a sufficient standard to ensure informed consent and full participation in the research

发起方

niversity of Bristol